Beijing Tiantan Biological Products Co., Ltd. (SHA:600161)
China · Delayed Price · Currency is CNY 18.80
-0.29 (-1.52%)
Oct 27, 2025, 2:45 PM CST
SHA:600161 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 1,316 | 1,549 | 1,110 | 880.92 | 760.01 | 639.01 | Upgrade |
Depreciation & Amortization | 324.09 | 324.09 | 268.02 | 179.75 | 157.15 | 132.75 | Upgrade |
Other Amortization | 38.73 | 38.73 | 20.81 | 12.39 | 8.38 | 9.45 | Upgrade |
Loss (Gain) From Sale of Assets | -0.04 | -0.04 | 0.05 | -15.63 | -0.51 | 0.12 | Upgrade |
Asset Writedown & Restructuring Costs | 53.59 | 53.59 | 1.21 | 2.1 | 15.09 | 0.57 | Upgrade |
Loss (Gain) From Sale of Investments | -63.93 | -63.93 | -37.21 | -28.13 | -12 | -1.15 | Upgrade |
Provision & Write-off of Bad Debts | 9.74 | 9.74 | -0.65 | 1.26 | -0.14 | -0.55 | Upgrade |
Other Operating Activities | -376.65 | 572.18 | 405.98 | 327.41 | 314.14 | 307.97 | Upgrade |
Change in Accounts Receivable | -473.12 | -473.12 | 1,029 | -221.05 | -351.21 | -82.48 | Upgrade |
Change in Inventory | -579.84 | -579.84 | -514.44 | -181.5 | 30.96 | -222.66 | Upgrade |
Change in Accounts Payable | -613.1 | -613.1 | 98.57 | 167.42 | 66.15 | -73.05 | Upgrade |
Operating Cash Flow | -362.08 | 819.78 | 2,394 | 1,126 | 980.35 | 702.11 | Upgrade |
Operating Cash Flow Growth | - | -65.75% | 112.57% | 14.86% | 39.63% | 9.28% | Upgrade |
Capital Expenditures | -783.67 | -1,067 | -1,078 | -1,354 | -1,132 | -608.91 | Upgrade |
Sale of Property, Plant & Equipment | 0.17 | 0.16 | 0.31 | 0.71 | 8.51 | 0.61 | Upgrade |
Cash Acquisitions | -958.62 | -963.78 | -1.58 | -36.36 | -29.33 | - | Upgrade |
Investment in Securities | 483 | 508.33 | -200 | - | -1,030 | -11.01 | Upgrade |
Other Investing Activities | -88.81 | -336.41 | 31.9 | -481.24 | -2.44 | -1.16 | Upgrade |
Investing Cash Flow | -1,348 | -1,859 | -1,247 | -1,871 | -2,185 | -620.47 | Upgrade |
Long-Term Debt Issued | - | - | - | - | - | 400 | Upgrade |
Long-Term Debt Repaid | - | -17.76 | -385.85 | -132.8 | -366.17 | - | Upgrade |
Net Debt Issued (Repaid) | 235.21 | -17.76 | -385.85 | -132.8 | -366.17 | 400 | Upgrade |
Issuance of Common Stock | - | - | - | - | 3,332 | - | Upgrade |
Common Dividends Paid | -494.13 | -247.17 | -94.02 | -157.21 | -163.84 | -92.88 | Upgrade |
Other Financing Activities | -217.23 | -105.36 | -28.21 | -88.19 | -27.6 | -52.95 | Upgrade |
Financing Cash Flow | -476.15 | -370.29 | -508.08 | -378.2 | 2,774 | 254.17 | Upgrade |
Foreign Exchange Rate Adjustments | 0.01 | -0.04 | -0 | -0.05 | -0.01 | -0.22 | Upgrade |
Net Cash Flow | -2,186 | -1,410 | 638.58 | -1,123 | 1,570 | 335.59 | Upgrade |
Free Cash Flow | -1,146 | -247.63 | 1,316 | -228.02 | -151.35 | 93.2 | Upgrade |
Free Cash Flow Growth | - | - | - | - | - | -19.82% | Upgrade |
Free Cash Flow Margin | -17.84% | -4.11% | 25.40% | -5.35% | -3.68% | 2.71% | Upgrade |
Free Cash Flow Per Share | -0.57 | -0.13 | 0.66 | -0.11 | -0.08 | 0.05 | Upgrade |
Cash Income Tax Paid | 745.88 | 636.71 | 582.34 | 412.48 | 386.75 | 363.05 | Upgrade |
Levered Free Cash Flow | -2,054 | -1,336 | 1,047 | -348.46 | -470.29 | -127.06 | Upgrade |
Unlevered Free Cash Flow | -2,048 | -1,332 | 1,049 | -346.96 | -468.36 | -125.2 | Upgrade |
Change in Working Capital | -1,664 | -1,664 | 625.47 | -234.08 | -261.77 | -386.05 | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.